SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: David G who wrote (5135)8/25/1998 7:21:00 AM
From: James Baker  Respond to of 9523
 
David G:
Have you heard of a growth company by any chance? They can even be as large as PFE.
Ignore the high P/E. >>>>>>>>>>>>>

Buyers at 121 were thinking the same thing. They are just so happy to have owned this great growth company for the last several months.

PE does matter eventually. That is why the 150 stock price for this year is starting to look like pie in the sky hope NOT reality.
Even the greatest companies can become overpriced on hype and only growing their earnings into the inflated price will all further stock gain.
Buying at 100-105 for a long term investor will prove to be very rewarding, but don't expect 30-40%/yr gains any more. The stock price is actually likely to gain less than the earnings growth as the PE backs off to more reasonable levels for a company growing at 18-22%/yr over the long term.
Jim